Recent findings demonstrated that endogenous expression of CCRK protein in hepatoma cells activates β-catenin/TCF signaling and in turn prompts the expression of downstream targets, such as CCND1 and EGFR44–46. The gene discussed is CDK20; the disease is hepatocellular carcinoma.